【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
• Pipeline analysis
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by product
• Cell therapy
• Ethical issues of stem cell research
• Global cell therapy market
• Tissue scaffold
• Global tissue scaffold market
• Gene therapy
• Gene therapy market in Europe
PART 08: Market segmentation by application
• Dermatology
• Musculoskeletal
• Ocular
• Cardiovascular
PART 09: Geographical segmentation
• Regenerative medicine market in Americas
• Regenerative medicine market in EMEA
• Regenerative medicine market in APAC
PART 10: Market drivers
• Increased prevalence of chronic diseases
• Funding by governments in regenerative medicine
• Increased focus on cell therapy products
• Technological innovations
PART 11: Impact of drivers
PART 12: Market challenges
• Stringent regulatory standards impeding product approvals
• Ethical challenges in stem cell research
• High cost and failure rate in clinical trials
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Increase in strategic alliances
• Increased number of regenerative medicine in the pipeline
• Gene therapy trending toward geographic expansion
PART 15: Vendor landscape
• Competitive scenario
• Acelity
• Medtronic
• MiMedx Group
• Organogenesis
• UniQure
• Zimmer Biomet
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Overview of key sectors involved in regenerative medicine
Exhibit 03: Key sectors in regenerative medicine 2015
Exhibit 04: SBIR and STTR programs
Exhibit 05: Clinical trials 2014
Exhibit 06: Number of clinical trials and products in regenerative medicine market 2014
Exhibit 07: Pipeline of regenerative medicines for CVDs
Exhibit 08: Pipeline of regenerative medicines for central nervous system, orthopedic, and ocular disorders
Exhibit 09: Pipeline of regenerative medicines for dermatology and diabetes
Exhibit 10: Pipeline of regenerative medicines for oncology
Exhibit 11: Global regenerative medicine market 2015-2020 ($ billions)
Exhibit 12: Five forces analysis
Exhibit 13: Global regenerative medicine market by product
Exhibit 14: Global regenerative medicine market by product 2015
Exhibit 15: Cell therapy: Overview
Exhibit 16: Ethical issues faced in different cell therapy research category
Exhibit 17: Stem cell research policies in emerging countries in Americas
Exhibit 18: Stem cell research policies in EMEA
Exhibit 19: Stem cell research policies in APAC
Exhibit 20: Key cell therapy products marketed in the US
Exhibit 21: Key cell therapy products marketed in EMEA
Exhibit 22: Key marketed cell therapy products in APAC
Exhibit 23: Opportunity analysis of cell therapy in global regenerative medicine market
Exhibit 25: Collaborations for R&D of tissue scaffold
Exhibit 26: Opportunity analysis of tissue scaffold in regenerative medicine market
Exhibit 27: Global tissue scaffold market 2015-2020 ($ billions)
Exhibit 28: Recent M&A in tissue scaffold market
Exhibit 29: Gene therapy products in Europe
Exhibit 30: Opportunity analysis of gene therapy in global regenerative medicine market
Exhibit 31: Gene therapy market in Europe 2015-2020 ($ billions)
Exhibit 32: European Commission support in gene transfer and gene therapy projects
Exhibit 33: Global regenerative medicine market by application
Exhibit 34: Global regenerative medicine market by application 2015
Exhibit 35: Overview of dermatology segment in global regenerative medicine market
Exhibit 36: Pipeline of regenerative medicine for dermatology
Exhibit 37: Overview of musculoskeletal segment in global regenerative medicine market
Exhibit 38: Overview of ocular segment in global regenerative medicine market
Exhibit 39: Overview of cardiovascular segment in global regenerative medicine market
Exhibit 40: Global regenerative medicine market by geography 2015
Exhibit 41: Global regenerative medicine market by geography 2020
Exhibit 42: Funding by federal agencies for R&D of regenerative medicine 2014 ($ millions)
Exhibit 43: Regenerative medicine market in Americas 2015-2020 ($ billions)
Exhibit 44: Distribution of 45 cell therapy vendors in Europe 2011
Exhibit 45: Regenerative medicine market in EMEA 2015-2020 ($ billions)
Exhibit 46: Regenerative medicine market in APAC 2015-2020 ($ billions)
Exhibit 47: Key developments in regenerative medicine market in Japan 2015
Exhibit 48: Global regenerative medicine market by geography 2015-2020
Exhibit 49: Global regenerative medicine market by geography 2015-2020 ($ billions)
Exhibit 50: Breakdown of CIRM funding in various stem cell research studies 2014 ($ billions)
Exhibit 51: Active programs under CIRM 2014
Exhibit 52: Funding by European Commission for regenerative medicine
Exhibit 53: Impact of drivers
Exhibit 54: Impact of drivers and challenges
Exhibit 55: Major strategic alliances in global regenerative medicine market
Exhibit 56: Mid- and late-stage pipeline products for regenerative medicine
Exhibit 57: Clinical trials on gene therapy for various indications
Exhibit 58: Vendors in global regenerative medicine market
Exhibit 59: Acelity: Business segmentation by revenue 2015
Exhibit 60: Acelity: Regenerative medicine revenues and YoY growth rate 2013-2015 ($ millions)
Exhibit 61: Acelity: Metrics analysis
Exhibit 62: Medtronic: Metrics analysis
Exhibit 63: MiMedx Group: Metrics analysis
Exhibit 64: Organogenesis: Metrics analysis
Exhibit 65: UniQure: Metrics analysis
Exhibit 66: Zimmer Biomet: Metrics analysis
Exhibit 67: Other prominent vendors
【レポート販売概要】
■ タイトル：再生医療の世界市場：細胞治療、組織スキャフォールド、遺伝子治療■ 英文：Global Regenerative Medicine Market 2016-2020
■ 発行日：2016年5月16日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9465
■ 調査対象地域：グローバル
- 後発医薬品の世界市場：機会、課題、戦略、市場予測A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights. Already prevalent in the U.S., Europe and much of the developing world, generic drugs are now finding their way into previously untapped markets suc …
- バイオマーカーの世界市場予測（～2021年）：安全性マーカー、予測マーカー、代替マーカー、薬力学マーカー、予後マーカーThe global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021.Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker …
- 三輪（3W）運搬車の世界市場2017-2021About 3W Goods Carrier The 3Ws are mostly used as a means of public transport and goods carriage for short to medium distances in regions where less public transport, underdeveloped logistics operations, and low disposable income prevails. Developing and underdeveloped nations like India, China, other Asian countries, and some Latin American and African countries are the major markets for 3W goods …
- 世界の政府部門におけるDNA分析市場2015-2019The adoption of mobile applications for DNA analysis is a key trend in the global DNA analysis market. Technavio's market research analysts project a market growth rate of close to 14% until 2019. It is used for purposes that include identifying criminals involved on charges of homicide. DNA analysis is also being used to identify victims of natural calamities and troops on the battlefield. Anothe …
- UAEの石油・ガス産業における中流（Midstream）市場展望United Arab Emirates Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing Summary "United Arab Emirates Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in Unite …
- Abbott Laboratories：市場シェア分析Abbott Laboratories Market Share Analysis Summary GlobalData’s new report, “Abbott Laboratories Market Share Analysis” provides in-depth information on Abbott Laboratories’s market position in the different medical equipment markets it operates in. The report provides Abbott Laboratories market share information in 10 key market categories – Interventional Cardiology, Infectious Immunology, Geneti …
- コンクリート結合剤の世界市場予測：セメント混合ラテックス系、エポキシ系The global concrete bonding agents market is projected to reach USD 3.84 Billion by 2021, at a CAGR of 7.6%. It is projected to reach 5,736.3 KT, at a CAGR of 6.3% from 2016 to 2021 by volume. Rising incomes of the middle class population in emerging countries such as India, Thailand, Indonesia, and Vietnam and the preference in repairing existing infrastructure rather than constructing new ones a …
- モバイルコンテンツの世界市場：ゲーム、動画、オーディオ、テキストTechnavio's market research analyst estimates the global mobile content market to exhibit an impressive market growth rate during the forecast period. The increasing adoption of smartphones and tablets is a critical factor that propels growth in this market and results in its striking market value of more than USD 170 billion by 2019. Low entry barrier for content developers is the key driver for …
- 2014年戦略提言：日本の治療薬物モニタリング(TDM)市場This new 247-page report from Venture Planning Group provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Car …
- ナノメディシン（ナノ医療）の世界市場及びパイプラインインサイトNanomedicines or nanotherapeutics is an emerging field in which nanotechnology principles are used to design and develop better therapeutics having high safety and efficacy profiles. It is a multidisciplinary approach utilizing knowledge from allied fields like biotechnology and pharmacology in drug development program. Novel modalities for cancer treatment, targeted drug delivery, biosensors, ima …
- 世界の非小細胞肺癌(NSCLC)治療市場：生物学的製剤、分子標的治療About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer deaths worldwide, and the incidence of lung cancer is increasing significantly. Lung cancer is the common cause of mortality and morbidity not only in developed countries but also in developing coun …
- 自動車タペットの世界市場：フラットタペット、ローラタペットAbout automotive tappets Tappets, also termed as cam follower or valve lifter, run on the camshaft that is made to move vertically by the action of the rotating cam. These are small member interposed between each camshaft lobe for valve lifting mechanism. The side valves lift upwards where the overhead valves are depressed to lift or open the side valves or vice versa. As the camshaft rotates, eac …
- ガラス食器の世界市場2019-2023About this market Launch of smartphone-based applications by vendors to drive market growth. Smartphone applications are becoming a powerful medium to deliver information to consumers. As these applications provide a better customer interface and extensive information about products. it leads to enhanced consumer experience and creates a factor of differentiation about the brand. As there are diff …
- ピリドキサミン二塩酸塩の世界市場2015Pyridoxamine Dihydrochloride (CAS 524-36-7) Market Research Report 2015 aims at providing comprehensive data on Pyridoxamine Dihydrochloride market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Pyridoxamine Dihydrochloride description, covers its application areas, manufacturing methods, patterns. It captures Pyridoxamine Dihydrochloride market trend …
- 世界主要国におけるライム病検査市場2015The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
